Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Patent strengthens global intellectual property protection for QTORIN™ rapamycin, Palvella’s lead product candidate from the QTORIN™ platform, in development for serious, rare skin diseases and...
-
Innovative non-hallucinogenic approach combines MEAI with Palmitoylethanolamide to tackle major depressive disorder, addressing a surging market expected to surpass $25 billion by 2030 Vancouver,...
-
VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones tecnológicas especializado en drones con...
-
ZenaTech’s ZenaDrone Announces the Filing of a Patent for its Maritime Defense System Combining ZenaDrone 2000 Interceptor Drone and IQ Glider Autonomous M
-
Key combination for the treatment of Small Cell Lung Cancer MADRID and CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage...
-
Rancho Cordova, CA, March 10, 2026 (GLOBE NEWSWIRE) -- MetalCloak, the industry leader in high-performance suspension systems and precision off-road engineering, today announced the continued...
-
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Templafy, die führende KI-gestützte Plattform zur Dokumentenerstellung, die es Fachleuten ermöglicht, mit höchster Effizienz präzise, richtlinienkonforme...
-
NEW YORK, 10 mars 2026 (GLOBE NEWSWIRE) -- Templafy, la principale plateforme de génération de documents alimentée par l’IA qui permet aux professionnels de créer des documents précis, conformes et...
-
Innovative non-hallucinogenic treatment combines MEAI with Palmitoylethanolamide to address obesity and metabolic dysfunction-associated steatotic liver disease, tapping into a rapidly growing market...
-
Templafy, the leading AI-powered document generation platform for professionals, announces the company’s first patent for document generation technologies.